glp 1 anesthesia recommendations GLP-1 drugs and aspiration risk GLP-1 RECEPTOR AGONISTS BEFORE GENERAL

Patients Using Wellness Peptides Have No Reliable Information About Whether They Are Safe or Effective, ECRI and ISMP Warn New joint white paper asserts commercial market for compounded peptide products has outpaced the clinical evidence

A review of serotonin syndrome emphasizes that the syndrome is a spectrum of toxicity most often precipitated by polypharmacy and dose increases

Bajuk Studen K, Pfeifer M, Cardiometabolic risk in polycystic ovary syndrome, Endocr Connect

This is why we see growing interest in Mycotherapy (medicinal mushrooms) to support gut health and hormonal homeostasis in GLP-1 patientshelping to balance the system while naturally mitigating common digestive side effects